4-Chlorophenyl(4-chlorophenyl)acetate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚酯
• 英文名称: 4-Chlorophenyl(4-chlorophenyl)acetate
• 英文别名: (4-chlorophenyl) 2-(4-chlorophenyl)acetate
• 化学式: C₁₄H₁₀Cl₂O₂
• 分子量: 281.1
• InChiKey: NTJKTOWZWRHAKB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Substituted alkyl amido piperidines
  申请人：Synaptic Pharmaceutical Corporation

  公开号：US20040186103A1

  公开（公告）日：2004-09-23

  This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of reducing the body mass of a subject which comprises administering to the subject an amount of a compound of the invention effective to reduce the body mass of the subject. This invention further provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject's depression and/or anxiety.

  这项发明涉及选择性拮抗黑色素浓缩激素-1（MCH1）受体的化合物。该发明提供了一种包括该发明化合物的治疗有效量和药学上可接受的载体的药物组合物。该发明提供了一种由结合本发明化合物的治疗有效量和药学上可接受的载体制成的药物组合物。该发明还提供了一种制备药物组合物的方法，包括结合本发明化合物的治疗有效量和药学上可接受的载体。该发明还提供了一种减少受试者体重的方法，包括向受试者施用本发明化合物的有效量以减少受试者的体重。该发明还提供了一种治疗患有抑郁症和/或焦虑症的受试者的方法，包括向受试者施用本发明化合物的有效量以治疗受试者的抑郁症和/或焦虑症。
• Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
  申请人：——

  公开号：US20020103235A1

  公开（公告）日：2002-08-01

  The present invention discloses novel substituted imidazole compounds which have either or dual histamine-H 1 and H 3 receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such imidazoles as well as methods of using them to treat allergy, inflammatory and CNS-related diseases and others.

  本发明揭示了新型取代咪唑化合物，其具有单一或双重组织胺-H1和H3受体拮抗活性，以及制备此类化合物的方法。在另一实施例中，本发明揭示了包含这些咪唑类化合物的药物组合物，以及使用它们治疗过敏、炎症和中枢神经系统相关疾病等方法。
• [EN] N-ACYL SULFAMIC ACID ESTERS (OR THIOESTERS), N-ACYL SULFONAMIDES, AND N-SULFONYL CARBAMIC ACID ESTERS (OR THIOESTERS) AS HYPERCHOLESTEROLEMIC AGENTS<br/>[FR] ESTERS (OU THIOESTERS) D'ACIDE N-ACYL SULFAMIQUE, N-ACYL SULFONAMIDES ET ESTERS (OU THIOESTERS) DE L'ACIDE N-SULFONYL CARBAMIQUE UTILISES COMME AGENTS HYPERCHOLESTEROLEMIQUES
  申请人：WARNER-LAMBERT COMPANY

  公开号：WO1994026702A1

  公开（公告）日：1994-11-24

  (EN) The present invention is directed to compounds useful for the regulation of cholesterol of formula (I), methods for using them and pharmaceutical compositions thereof. In Formula (I) X and Y are oxgen, sulfur, or (CR'R')n wherein n is 1 to 4; R is hydrogen, alkyl, or benzyl; R1 and R2 are phenyl, substituted phenyl, naphthyl, substituted naphthyl, an aralkyl group, an alkyl chain, adamantyl, or a cycloalkyl group.(FR) La présente invention concerne des composés de la formule (I) utiles pour la régulation du cholestérol, ainsi que leurs procédés d'utilisation et des compositions pharmaceutiques les contenant. Dans cette formule, X et Y représentent oxygène, soufre ou (CR'R')n, où n est compris entre 1 et 4, R représente hydrogène, alkyle ou benzyle, R1 et R2 représentent un groupe phényle, phényle substitué, naphtyle, naphtyle substitué, aralkyle, alkyle, adamantyle ou cycloalkyle.

  本发明涉及一种用于调节胆固醇的化合物，其化学式为(I)，以及使用它们的方法和制备它们的药物组合物。在化学式(I)中，X和Y分别代表氧、硫或(CR'R')n，其中n为1至4；R代表氢、烷基或苯甲基；R1和R2分别代表苯基、取代苯基、萘基、取代萘基、芳基烷基、烷基链、金刚烷基或环烷基。
• Diaryl compounds and pharmaceutical formulations containing them
  申请人：THE WELLCOME FOUNDATION LIMITED

  公开号：EP0028305A1

  公开（公告）日：1981-05-13

  Known and novel compounds of formula (I) wherein Ar are the same or different and each is a substituted or unsubstituted phenyl group and Z is a bond, sulphur, -CHOH, or -C=O; and X is oxygen, sulphur, -CH2 or -NH- when Y is -CH2; or X is -CH2 when Y is oxygen; or X - Y together is -CH=CH, are active against viruses, especially rhinoviruses. Methods for producing the compounds are described, as are pharmaceutical formulations and methods for administering the compounds to cure or prevent rhinoviral infections.

  已知和新型的式(I)化合物 其中 Ar 相同或不同，且各为取代或未取代的苯基，以及 Z 是键、硫、-CHOH 或 -C=O；以及 当 Y 为-CH2 时，X 为氧、硫、- 或-NH-；或 当 Y 是氧时，X 是- ；或 X-Y合起来是-CH=CH，对病毒，特别是鼻病毒有活性。本文介绍了生产这些化合物的方法，以及使用这些化合物治疗或预防鼻病毒感染的药物制剂和方法。
• 4,5,6,7-Tetrahydro-1H-imidazo[4,5-c]pyridine derivatives and analogs having antihypertensive activity
  申请人：WARNER-LAMBERT COMPANY

  公开号：EP0245637B1

  公开（公告）日：1991-10-16